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Arne Gerhard Schwindt, MD,a,b Giuseppe Panuccio, MD,a,b Konstantinos P. Donas, MD, PhD,a,b
Luca Ferretto, MD,c Martin Austermann, MD,a and Giovanni Torsello, MD,a,b Münster, Germany; and
Padua, Italy
Introduction:The purpose of this study was to report the early and late results of primary stenting for focal atherosclerotic
lesions of the infrarenal aorta.
Methods: A retrospective analysis of 52 consecutive patients treated for infrarenal occlusive aortic disease with primary
stenting between January 2002 and November 2009 was performed. Original angiographic imaging, medical records,
and noninvasive testing were reviewed. Primary stenting was the first line of treatment. Perioperative technical success
and Kaplan-Meier estimates for patency and survival were calculated.
Results: The majority of the patients (43) were treated for severe claudication (Rutherford III; 82.7%), 5 for ischemic rest
pain (Rutherford IV; 9.6%), and 4 for minor tissue loss (Rutherford V; 7.7%). Aortic stenosis was found in 40 cases
(76.9%) and occlusion in 12 (23%). Perioperative hemodynamic success was 100%. All patients had an improvement of
ankle brachial index (ABI)>0.10. Clinical improvement was found in 96%. Early surgical revision was necessary for aortic
rupture in 1 patient. One death occurred for pneumonia. The mean follow-up time was 39.4  27.2 months. Ten
reinterventions (19%) were needed for symptom recurrence. The estimated assisted primary patency at 9 years was 96%
and the mean survival time was 86.6 months.
Conclusion: Primary stenting offers safe and durable results and should be considered as the first line of treatment for focal
aortic lesions. ( J Vasc Surg 2011;53:1550-6.)
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mUntil the 1980s, the surgical approach was considered
as the standard treatment for occlusive disease. Despite a
good long-term patency rate, open surgery has a perioper-
ative mortality rate between 3.3% and 4.4%, and perioper-
ative complication rates between 8.3% and 12.2%.1
Percutaneous transluminal angioplasty (PTA) and
lately primary stenting have been proposed as alternative
solutions for lesions localized at the level of the infrarenal
abdominal aorta.2,3 However, few minor series have been
published and no agreement has been found regarding
which procedure should be considered as a first line treat-
ment for focal aortic stenosis and occlusion.3-9
The purpose of this study was to report the early and
late results of our experience with primary stenting for focal
atherosclerotic lesions of the infrarenal aorta. Considering
the limited number of publications on this topic, our data
may contribute to up-to-date evidence.
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1550ATERIALS AND METHODS
All patients undergoing endovascular treatment be-
ween February 2002 and November 2009 for occlusive
rterial disease and with atherosclerotic lesions localized at
he level of the infrarenal abdominal aorta were reviewed.
atients with common iliac artery lesions without involve-
ent of the aorta or with nonatherosclerotic aortic stenosis
uch as coartatio aortae abdominalis (mid aortic syndrome)
ere not included in this study. Indications for treatment
ere stenosis greater than 60% as determined by angio-
rams and with a pressure gradient through the lesion
reater than 15 mm Hg. Treatment of concomitant iliac
esions were considered as associated procedures and re-
orted.
Patient characteristics, comorbidities, operative data, and
ostoperative complications were prospectively gathered in a
omputer database. Follow-up was performed at 3, 6, and 12
onths after treatment and at 12-month intervals thereafter.
hysical examination, ankle brachial index (ABI) at rest, tread-
ill test, and Duplex scan were assessed.
Procedures. The majority of procedures were per-
ormed in the endovascular suite of our department with
he patient under local anesthesia. Spinal anesthesia was
erformed when surgical reconstruction of the femoral
essels was necessary during the same procedure.
An intra-arterial bolus of heparin (100 UI/Kg) was
iven to every patient. The majority of lesions were recana-
ized with 0.035 hydrophilic J-type Terumo or Terumo
tiff guide wires (Terumo Corp, Tokyo, Japan). In cases
ith demanding groin (eg, previous surgery, obesity, skin
ycosis), the antegrade recanalization was performed
hrough a left brachial approach using a 90-cm long sheath
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Volume 53, Number 6 Schwindt et al 1551(6 French Destination Straight CCV, Terumo Corpora-
tion, Tokyo, Japan, or Straight Flexible TBVKSAW, Cook,
Bloomington, Ind).
In the case of challenging transfemoral punctures, vas-
cular access was achieved under road map guide or using a
Doppler ultrasound needle (PDAccess, Vascular Solutions,
Minneapolis, Minn).
The intraluminal technique was preferred to cross the
lesion. In case of subintimal recanalization, we avoided
re-entry close to the renal arteries. In chronic occlusion, it
could be useful to place the sheath close to the lesion and
use the funnelling effect of the hard plaque part. With this
strategy, the wire is more likely to cross through the softer
part intraluminally. Due to the duration of symptoms,
locoregional thrombolysis or mechanical thrombectomy
devices were not used.
Primary stenting was the first line of treatment. Predi-
lation was performed for all cases with complete occlusion
to achieve a smooth stent passage through the lesion. The
stent selection was based on the characteristics of the lesion
as found in the intraprocedural angiography. The length
chosen was the shortest appropriate for complete coverage
of the lesion. In the case of lesions just above the aortic
bifurcation, kissing stent technique of the common iliac
artery was used. Self-expandable stents were preferred for
long lesions (Luminex, Austin, Tex; Bard, Covington, Ga;
Protégé, ev3 Endovascular, Plymouth, Minn; Smart, Cor-
dis Corporation, Miami Lakes, Fla; Wallstent, Boston Sci-
entific, Natick, Mass). Alternatively, in lesions involving the
aortic bifurcation, or when more radial force was needed,
balloon-expandable systems were used (Genesis, Cordis
Corporation; Omnilink, Abbott Laboratories, Abbott
Park, Ill). Stent grafts (Talent, Medtronic Vascular, Santa
Rosa, Calif; Zenith, Cook Medical, Bloomington, Ind)
were used in the presence of a friable thrombus to prevent
eventual embolization.
Post dilation was performed when self-expandable
stents were implanted. To avoid risky over dilatation, the
balloon size did not exceed an outer diameter of 14 mm,
even if the aortic diameter proximal to the lesion was larger.
Pressures from 5 atmospheres up to 12 atmospheres were
applied over a mean time of 120 seconds. To avoid vessel
rupture, pressure was reduced immediately in the event of
remarkable pain.
The completion angiography always included a check
of the below knee run off, to exclude eventual distal embo-
lization.
Hemostasis was achieved using an Angioseal closure
device (St. Jude Medical, St Paul, Minn) for sheaths up to
8F and with the Prostar XL device (Abbott Vascular, Red-
wood City, Calif) if larger sheaths were used. For the
transbrachial puncture sites, manual pressure for 10 to 15
minutes and a pressure dressing for 24 hours were applied.
After the procedure, double antiplatelet treatment with
aspirin (100 mg/day) and clopidogrel (75 mg/day) was
administered for 6 weeks, and then monotherapy with
aspirin (100 mg/day) was continued unless contraindi-
cated. rTechnical success was considered to have been attained
or residual stenosis 30%. Immediate hemodynamic suc-
ess was determined by an increase in ABI of 0.10 from
aseline at the first clinical follow-up. Clinical success was
efined as improvement in walking distance, absence of rest
ain, and healing of trophic lesion changes after stent
lacement.
Patency was defined as stenosis 50% at color-coded
uplex scan. Angiography was performed in the case of
ecurrence of symptoms, decrease in ABI measurements
0.1, or suspicion of restenosis in color-coded duplex
can because of an increase of peak systolic velocity ratio.
Statistical analysis. Median and interquartile range
IQR) values were calculated for all the continuous vari-
bles. Categorical variables were compared with the 2 or
he Fischer exact test, and means were compared using the
olmogorov-Smirnov test. The persistence of patency dur-
ng follow-up was reported by Kaplan-Meier life-table anal-
sis. The influence of the lesion type according to the
ransAtlantic Inter-Society Consensus (TASC) classifica-
ion on restenoses was tested with the log-rank test. All the
nalyses were performed using SPSS package, 17.0 version
SPSS, Chicago, Ill).
ESULTS
During the study period, a total of 52 patients
atched the enrollment criteria. Demographic data, risk
actors, and Rutherford classification are summarized in
able I. The majority of the patients presented with a
tenosis (stenosis n 40, occlusion n 12; Table II) not
nvolving the aortic bifurcation (n  39; Fig 1). Associ-
ted atherosclerotic lesions were found at the level of the
emoral bifurcation in 7 patients and of the iliac artery in
patients.
In 13 patients (25%), a kissing stent technique with
ilateral stenting of the common iliac arteries was per-
ormed. In 2 patients, a self-expandable stent graft was used
Table III). Overall, only 2 patients, both treated with a
elf-expandable stent, required an adjunctive balloon-
xpandable stent for stent recoil. Completion angiography
able I. Baseline patient characteristics
ariable Value (n  52)
ge years old, median (IQR) 64.1 (14.7)
ale, no. (%) 22 (42.3)
moking, no. (%) 25 (48.1)
ypertension, no. (%) 37 (71.2)
iabetes, no. (%) 10 (19.2)
ypercholesterolemia, no. (%) 30 (57.7)
hronic renal failure, no. (%) 3 (5.8)
revious MI no. (%) 12 (23.1)
reoperative clinical status (by
Rutherford Classification)
III, no. (%) 43 (82.7)
IV, no. (%) 5 (9.6)
V, no. (%) 4 (7.7)
QR, Interquartile range; MI, myocardial infarction.evealed no distal embolization.
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June 20111552 Schwindt et alIn 16 patients, one or more associated procedures were
necessary: femoral endarterectomy (n  9), stenting of
external iliac artery (n  6), and femorofemoral cross-over
bypass (n  4). One patient with total aortic occlusion
showed acute bilateral peripheral ischemia and was treated
in an urgent setting. Bifemoral surgical approach, wire-
guided Fogarty maneuver, and following stenting were
performed.
Hemodynamic success was achieved in all the cases. All
patients had an improvement of ABI 0.10 median in-
crease from 0.5 (IQR 0.25) to 1.0 (IQR 2.2) (P  .001).
Clinical improvement was found in all but 2 patients with
Rutherford status in class III.
One major complication was related to an aortic rup-
ture and required surgical conversion to aortoiliac bypass.
One patient died within the first 30 days after the procedure
due to pneumonia. One minor complication occurred  a
groin hematoma requiring surgical revision. Univariate
analysis showed no risk factors significantly correlated with
major events (Table IV, online only).
The mean follow-up time was of 39.4 months (range,
1-117; SD 27.2). Nine patients experienced recurrence
of symptoms. Eight in-stent restenoses were found and
treated by re-PTA. One patient showed proximal pro-
gression of the disease and required an additional aortic
stent (Fig 2). One patient developed an acute occlusion
of the stent and required surgical treatment with aortic
iliac bypass.
In total, 11 reinterventions were performed during
the follow-up period. Eighty-five percent (n 44) of the
patients achieved unlimited walking distance during fol-
low up. One amputation was performed in a patient with
patent aorto iliac inflow caused by progressive distal
disease (Table V, online only). Kaplan-Meier estimates
an assisted primary patency of 96% at 9 years (Fig 3). The
mean survival time estimated was 86.6 months (95%
confidence interval 70.9-102.2). The log-rank test does
not show statistical differences in primary and assisted
primary patency rate between TASC B and D lesions
(respectively, P  .4 and P  .3).
DISCUSSION
Isolated obstructive atherosclerotic pathology of the
Table II. Baseline lesions characteristic
Variable Value (n  52)
Lesion type
TASC B, no. (%) 40 (76.9)
TASC D, no. (%) 12 (23.1)
Lesion site
Abdominal aorta, no. (%) 39 (75.0)
Aortic Carrefour, no. (%) 13 (25.0)
Associated peripheral lesion
Iliac occlusions/stenoses, no. (%) 10 (19.2)
CFA stenoses, no. (%) 7 (13.5)
CFA, Common femoral artery; TASC, TransAtlantic Inter-Society Consen-
sus.infrarenal aorta is a relatively rare entity, and few experi- onces have been published.10 To increase the evidence
elating to endovascular treatment, we reported our early
nd late results for primary stenting in this disease.
Consistent with the literature, our population was pre-
ominantly made up of young heavily smoking women
ith multisegmental atherosclerotic involvement as shown
y the number of patients (n  16; 31%) requiring one or
ore adjunctive procedures.11
According to TASC II, stenoses of the infrarenal aorta
ith a lesion length 3 cm (type B) should be treated by
ndovascular techniques. On the contrary, open surgery
hould be the treatment of choice for infrarenal occlusions
D category) because of more durable outcomes.12 How-
ver, significant perioperative mortality and morbidity have
een described.13 A meta-analysis of 25 articles demon-
trated a cumulative 4.4% mortality rate and 12.2% major
omplication rate.1 A more recent analysis revealed a de-
rease in mortality and complication rates (3.3% and 8.3%,
espectively). The overall 5-year patency rate was 91% for
atients with claudication and 87% for patients with critical
imb ischemia.14,15 Patients not suitable for laparotomy
nderwent traditional extra-anatomic bypass revasculariza-
ion. The results of these surgical strategies are not com-
etitive to those proven by aortobifemoral bypasses and are
ffected by graft infection.12
Two major complications are present within our series.
he first was a death at 30 days, due to an acute pneumonic
vent in a patient with chronic obstructive pulmonary
isease and chronic limb ischemia Rutherford class 6. This
as probably related to the severe comorbidities of the
atient who was not eligible for an open procedure. The
econd was an early aortic rupture with abdominal pain and
evere hypotension in a patient with aortic stenosis. An
mergent computed tomography (CT) revealed active
leeding near the aortic bifurcation. Due to the site of the
esion, and the endovascular skills of the surgeon on call, an
orto-iliac bypass was preferred to a stent graft, and the
atient made a good postoperative recovery. This second
omplication shows that surgical backup remains manda-
ory for the performance of this procedure.
One patient required surgical conversion 4 months
ater for a stent occlusion. This occurred in a 57-year-old
atient at the beginning of our experience. The patient was
nitially treated for bifurcation aortic stenosis and uni-iliac
cclusion by two kissing self-expandable stents with a di-
meter of 6 mm each. The probable reason for early treat-
ent failure was the comparatively low diameter and low
adial force of the chosen stents. The previous aortic stents
id not compromise the surgical correction.
Most of the published retrospective series dealing with
he endovascular treatment of aortic stenosis show good
esults with low perioperative complication rates. Recently,
large monocentric experience in endovascular aortic oc-
lusion treatment showed excellent short-term results, but
nfortunately one third of the patients had 1 month of
ollow-up.16 Our results confirm this data for stenoses and
cclusions also in the long term.
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 6 Schwindt et al 1553Fig 1. Angiography of a 70-year-old woman with focal aortic stenosis at the distal part of the aorta. A and B,
Through a right femoral retrograde approach it was possible to cross and stent the lesion with a single
self-expandable stent (Luminex, C.A. Bard). C and D, Computed tomography (CT) scan 2 years later shows the
stent integrity and the calcified aortic plaque (3D volume rendering modality, white arrow). On the left, a curved
planar reformation passing through the aortic lumen shows the absence of a restenosis.
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and 9 patients required a secondary endovascular procedure
for in-stent restenosis. Redo-PTAs of this type are not techni-
Table III. Material details based on the site of the lesion a
Technique Variable (mm) Med
Aortic tube stent Balloon diameter 9
(n  39) Stent diameter 14
Stent length 50
Aorto-iliac kissing Balloon diameter 6
stent (n  13) Stent diameter 7
Stent length 40
IQR, Interquartile range.
Fig 2. Secondary procedure in a patient with recurre
expandable stent. The intraoperative angiography shows
A 7F introducer sheath was placed to protect the lowe
self-expandable stent was deployed and postdilated (C)cally demanding and can be performed with a high success rate. iThe TASC lesion type did not significantly predict
he long-term outcome (Fig 3). In contrast with TASC
I recommendations, our results suggest primary stent-
he related technique
IQR Minimum Maximum
3 8 14
2 6 28
20 10 122
1.2 5 8
1 6 9
58.2 28 150
f symptoms 75 months after implantation of a self-
vo stenosis below the origin of the left renal artery (A).
renal artery through a left brachial access (B). A new
patency of the left renal artery was preserved (D).nd t
ian
.3
.5nce o
de no
r leftng as a viable option also for focal aortic occlusion. This
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Volume 53, Number 6 Schwindt et al 1555is probably explained by the lack of a specific classifica-
tion for short aortic occlusions, which are included with
the extensive aorto-iliac occlusions in group D.
Despite the absence of direct scientific evidence for the
superiority of the primary stent over the simple aortic PTA,
it is broadly accepted that primary stenting may help to
create a smooth cylindrical lumen thus minimizing throm-
bus formation and recoil in a relatively large vessel such as
the aorta where the possible neo-intimal hyperplasia seems
not to be crucial.9,17,18
After an aortic rupture in the beginning of our series,
we reduced our post-ballooning diameter. Previous articles
consider as target diameter the first aortic segment above
the lesion “free from disease,” instead of considering the
hemodynamic necessity of the run-off. In case of surgical
aorto-iliac reconstruction, the main body diameter of the
prosthesis is commonly 14 to 16 mm, giving good clinical
Fig 3. Primary patency (A) and assisted primary patency (B) in
52 patients with numbers at risk for each period (Kaplan-Meier).
Subgroup for occlusions (green line) and stenoses (blue line) are
also depicted. Dashed lines show SE value 10%.results. In our opinion, it is not necessary to exceed this riameter regardless of how large the proximal aorta is. This
trategy could reduce the risk of dangerous aortic overdila-
ion without compromising the clinical outcome.
There is also debate about the stent choice. As men-
ioned in the Method section of this article, our indications
or the use of balloon-expandable vs self-expandable stents
re mainly dictated by the localization of the lesion, and
ntergroup comparison was therefore not reasonable. Self-
xpandable stents offer several advantages such as the
maller French profile, and a delivery system that reduces
he risk of losing the stent. However, in 2 patients, the
adial force of the stent was insufficient, and an additional
alloon-expandable stent was needed. The recent introduc-
ion into the European market of a stent pre-mounted on
n angioplasty catheter with two concentric balloons could
urther improve the deployment of balloon-expandable
tents (NuMED, Hopkinton, NY).
In 2 cases, self-expandable stent grafts were used in the
uspicion of a higher risk of embolic event due to the
ppearance of the thrombus at the preoperative CT scan. In
oth cases, an adjunctive balloon-expandable stent was
eeded to expand the graft. These devices are dedicated for
neurysmatic disease, and the recoil may be explained by
ow radial force. Only recently, balloon-expandable cov-
red stents long enough (maximum 61 mm) to completely
over the segment involved (Advanta, Atrium, NH) have
ecome available. However, despite the widespread use of
are metal stents and intensive imaging of the postopera-
ive runoff vessel, no symptomatic or asymptomatic em-
olic events have been found in this series. In accordance
ith previous publications, this result suggests a low risk of
mbolic events for these patients and reduces the indication
or stent grafting. In our opinion, the use of these devices is
ntended as a bailout technique in the case of aortic rupture
nd should always be available. Bifurcated stent grafts for a
arrow lumen with high radial force are not yet available.
In addition to the limitation related to the retrospective
ature of the study, the small sample size could affect the
redictive value of univariate analyses. Furthermore, ad-
ances in endovascular technology and surgeons’ experi-
nce during the 7 years of the study were not taken into
ccount.
ONCLUSIONS
Endovascular and combined treatment of focal occlu-
ive aortic disease is a safe method with excellent clinical
utcomes. Bare metal stents should represent the standard
evice for treatment. Secondary procedures are needed but
re safe and effective, leaving the surgical option uncom-
romised. The feasibility of a randomized study comparing
ndovascular treatment to open surgery is low because of
he rarity of the disease. However, more data could help to
erform meta-analyses. Short aortic occlusions are not a
isk factor for the early and late patency rate and should be
owngraded from group TASCD. Advances in technology
ave already been made and are likely to improve future
esults.
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Volume 53, Number 6 Schwindt et al 1556.e1able V, online only. Perioperative and late
omplications
Value (n  52)
erioperative
Mortality 1 (1.9)
Groin complication (%) 1 (1.9)
Aortic rupture (%) 1 (1.9)
ate
Re-PTA (%) 8 (15.4)
Additional stent (%) 1 (1.9)
Aorto-iliac bypass (%) 1 (1.9)
Limb lost 1 (1.9)
TA, Percutaneous transluminal angioplasty.Table IV, online only. Univariate analysis of the
association between major complications and risk factors
Variable
Major complications
P
valueYes (n  2) No (n  50)
Age years, median (IQR) 73.3 (15.4) 63.5 (14.5) .8
Male, no. (%) 1 (50) 21 (42) 1
Smoking, no. (%) 1 (50) 24 (48) 1
Hypertension, no. (%) 2 (100) 36 (72) 1
Diabetes, no. (%) 0 (0) 10 (20) 1
Hypercholesterolemia, no. (%) 2 (100) 30 (60) .5
Chronic renal failure, no. (%) 0 (0) 3 (6) 1
Previous MI, no. (%) 0 (0) 12 (24) 1
Chronic limb ischemia, no. (%) 1 (50) 8 (16) .3
TASC D, no. (%) 1 (50) 11 (22) .4
Adjunctive procedures, no. (%) 1 (50) 15 (30) 1
